In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endosense: Growing Up Fast in AF

Executive Summary

Hoping to succeed in the elusive field of atrial fibrillation, Endosense is taking an anti-start-up strategy: focusing more on later-stage commercialization and market launch and less on technology vetting.
Advertisement

Related Content

Endosense: Facing Technology and Financing Challenges in AF
Advanced Cardiac Therapeutics Inc.
Device Companies Look Far and Wide for New Capital
Estech: Back From the Brink
AF Ablation: The Pulse of Innovation
In Brief January 2007
AF Ablation: Progress & Promise
Tapping the Potential of Atrial Fibrillation Devices
The Lonely World of European Device Start-Ups
The Lonely World of European Device Start-Ups

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel